Clinical trial data for the COVID-19 vaccine for children ages 5 to 11 shows no cases of rare myocarditis and an overall 91% effectiveness against symptomatic infections.

SUBSCRIBE to GMA3's YouTube page:
[ Ссылка ]

VISIT GMA's homepage:
[ Ссылка ]

FOLLOW GMA3:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]

свернуть